Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2008, 152(1):9-19 | DOI: 10.5507/bp.2008.002

CARDIOTROPHIN-1 REVIEW

David Stejskala,b, Viktor Ruzickac
a Department of Laboratory Medicine and Department of Internal Medicine, ©ternberk Hospital, Czech Republic
b Department of Medical Chemistry and Biochemistry, Faculty of Medicine and Dentistry, Palacky University, 775 15 Olomouc, Czech Republic
c BioVendor Laboratory Medicine, Brno, Czech Republic

Background: Cardiotrophin-1 is newly discovered chemokin with a lot of functions. Aim of our work was to describe most important of them.

Methods: systematically scan of available scientific resources.

Results: Cardiotrophin-1 stimulates the proliferation of cardiomyocytes. Cardiotrophin-1 expression and plasma values are elevated in individuals with heart failure and have high diagnostic efficacy for the heart failure. Plasma values are also an independent prognostic factor. Preliminary findings suggest that the determination of plasma cardiotrophin-1 may be useful for the follow-up of hypertensive heart disease in routine clinical practice. Cardiotrophin-1 also plays an important cardioprotective effect on myocardial damage, is a potent regulator of signaling in adipocytes in vitro and in vivo and potentiates the elevation the acute-phase proteins. Cardiotrophin-1 may play also an important protective role in other organ systems (such as hematopoietic, neuronal, developmental).

Conclusion: Cardiotrophin is a newly discovered chemokin with a lot of system effects and is stable in system circulation hence permitting its development in the routine clinical investigation.

Keywords: Acute Coronary Syndromes, Metabolic Syndrome, Cardiovascular Diseases, Cancers, Laboratory markers, Cardiotrophin-1, ELISA

Received: March 3, 2008; Accepted: April 25, 2008; Published: June 1, 2008  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Stejskal, D., & Ruzicka, V. (2008). CARDIOTROPHIN-1 REVIEW. Biomedical papers152(1), 9-19. doi: 10.5507/bp.2008.002
Download citation

References

  1. Pennica D, King KL, Shaw KJ, Luis E, Rullamas J, Luoh SM, Darbonne WC, Knutzon DS, Yen R, Chien KR, et al. Expression cloning of cardiotrophin 1, a cytokine that induces cardiac myocyte hypertrophy. Proc Natl Acad Sci U S A. 1995; 92:1142-6. Go to original source... Go to PubMed...
  2. Pennica D, Shaw KJ, Swanson TA, Moore MW, Shelton DL, Zioncheck KA, Rosenthal A, Taga T, Paoni NF, Wood WI. Cardiotrophin-1. Biological activities and binding to the leukemia inhibitory factor receptor/gp130 signaling complex. J Biol Chem. 1995; 270:10915-22. Go to original source... Go to PubMed...
  3. Peters M, Roeb E, Pennica D, Meyer zum Büschenfelde KH, Rose- John S. A new hepatocyte stimulating factor: cardiotrophin-1 (CT- 1). FEBS Lett. 1995; 372:177-80. Go to original source... Go to PubMed...
  4. Richards CD, Langdon C, Pennica D, Gauldie J. Murine cardiotrophin- 1 stimulates the acute-phase response in rat hepatocytes and H35 hepatoma cells. J Interferon Cytokine Res. 1996; 16:69- 75. Go to original source... Go to PubMed...
  5. Yoshida K, Taga T, Saito M, Suematsu S, Kumanogoh A, Tanaka T, Fujiwara H, Hirata M, Yamagami T, Nakahata T, Hirabayashi T, Yoneda Y, Tanaka K, Wang WZ, Mori C, Shiota K, Yoshida N, Kishimoto T. Targeted disruption of gp130, a common signal transducer for the interleukin 6 family of cytokines, leads to myocardial and hematological disorders. Proc Natl Acad Sci U S A. 1996; 93:407-11. Go to original source... Go to PubMed...
  6. Sheng Z, Pennica D, Wood WI, Chien KR. Cardiotrophin-1 displays early expression in the murine heart tube and promotes cardiac myocyte survival. Development 1996; 122:419-28. Go to original source... Go to PubMed...
  7. Ishikawa M, Saito Y, Miyamoto Y, Kuwahara K, Ogawa E, Nakagawa O, Harada M, Masuda I, Nakao K. cDNA cloning of rat cardiotrophin-1 (CT-1): augmented expression of CT-1 gene in ventricle of genetically hypertensive rats. Biochem Biophys Res Commun. 1996; 219:377-81. Go to original source... Go to PubMed...
  8. Benigni F, Fantuzzi G, Sacco S, Sironi M, Pozzi P, Dinarello CA, Sipe JD, Poli V, Cappelletti M, Paonessa G, Pennica D, Panayotatos N, Ghezzi P. Six diff erent cytokines that share GP130 as a receptor subunit, induce serum amyloid A and potentiate the induction of interleukin-6 and the activation of the hypothalamus-pituitary-adrenal axis by interleukin-1.Blood. 1996; 87:1851-4. Go to original source... Go to PubMed...
  9. Pennica D, Swanson TA, Shaw KJ, Kuang WJ, Gray CL, Beatty BG, Wood WI. Human cardiotrophin-1: protein and gene structure, biological and binding activities, and chromosomal localization. Cytokine. 1996; 8:183-9. Go to original source... Go to PubMed...
  10. Wollert KC, Taga T, Saito M, Narazaki M, Kishimoto T, Glembotski CC, Vernallis AB, Heath JK, Pennica D, Wood WI, Chien KR. Cardiotrophin-1 activates a distinct form of cardiac muscle cell hypertrophy. Assembly of sarcomeric units in series VIA gp130/ leukemia inhibitory factor receptor-dependent pathways. J Biol Chem. 1996; 271:9535-45. Go to original source... Go to PubMed...
  11. Pennica D, Wood WI, Chien KR. Cardiotrophin-1: a multifunctional cytokine that signals via LIF receptor-gp 130 dependent pathways. Cytokine Growth Factor Rev. 1996; 7:81-91. Go to original source... Go to PubMed...
  12. Pennica D, Arce V, Swanson TA, Vejsada R, Pollock RA, Armanini M, Dudley K, Phillips HS, Rosenthal A, Kato AC, Henderson CE. Cardiotrophin-1, a cytokine present in embryonic muscle, supports long-term survival of spinal motoneurons. Neuron. 1996; 17:63- 74. Go to original source... Go to PubMed...
  13. Benigni F, Sacco S, Pennica D, Ghezzi P. Cardiotrophin-1 inhibits tumor necrosis factor production in the heart and serum of lipopolysaccharide-treated mice and in vitro in mouse blood cells. Am J Pathol. 1996; 149:1847-50.
  14. Jin H, Yang R, Keller GA, Ryan A, Ko A, Finkle D, Swanson TA, Li W, Pennica D, Wood WI, Paoni NF. In vivo eff ects of cardiotrophin- 1. Cytokine 1996; 8:920-6. Go to original source... Go to PubMed...
  15. Robledo O, Fourcin M, Chevalier S, Guillet C, Auguste P, Pouplard- Barthelaix A, Pennica D, Gascan H. Signaling of the cardiotrophin- 1 receptor. Evidence for a third receptor component. J Biol Chem. 1997; 272:4855-63. Go to original source... Go to PubMed...
  16. Sheng Z, Knowlton K, Chen J, Hoshijima M, Brown JH, Chien KR. Cardiotrophin 1 (CT-1) inhibition of cardiac myocyte apoptosis via a mitogen-activated protein kinase-dependent pathway. Divergence from downstream CT-1 signals for myocardial cell hypertrophy. J Biol Chem. 1997; 272:5783-91. Go to original source... Go to PubMed...
  17. Robledo O, Chevalier S, Froger J, Barthelaix-Pouplard A, Pennica D, Gascan H. Regulation of interleukin 6 expression by cardiotrophin 1. Cytokine 1997; 9:666-71. Go to original source... Go to PubMed...
  18. Robledo O, Guillet C, Chevalier S, Fourcin M, Froger J, Pouplard- Barthelaix A, Pennica D, Gascan H. Hepatocyte-derived cell lines express a functional receptor for cardiotrophin-1. Eur Cytokine Netw. 1997; 8:245-52.
  19. Cheng JG, Pennica D, Patterson PH. Cardiotrophin-1 induces the same neuropeptides in sympathetic neurons as do neuropoietic cytokines. J Neurochem. 1997; 69:2278-84. Go to original source... Go to PubMed...
  20. Jin H, Yang R, Ko A, Pennica D, Wood WI, Paoni NF. Eff ects of cardiotrophin-1 on haemodynamics and cardiac function in conscious rats. Cytokine. 1998; 10:19-25. Go to original source... Go to PubMed...
  21. Stephanou A, Brar B, Heads R, Knight RD, Marber MS, Pennica D, Latchman DS. Cardiotrophin-1 induces heat shock protein accumulation in cultured cardiac cells and protects them from stressful stimuli. J Mol Cell Cardiol. 1998; 30:849-55. Go to original source... Go to PubMed...
  22. Chandrasekar B, Melby PC, Pennica D, Freeman GL. Overexpression of cardiotrophin-1 and gp130 during experimental acute Chagasic cardiomyopathy. Immunol Lett. 1998; 61:89-95. Go to original source... Go to PubMed...
  23. Thier M, Hall M, Heath JK, Pennica D, Weis J. Trophic eff ects of cardiotrophin-1 and interleukin-11 on rat dorsal root ganglion neurons in vitro. Brain Res Mol Brain Res. 1999; 64:80-4. Go to original source... Go to PubMed...
  24. Pulido EJ, Shames BD, Pennica D, O'leary RM, Bensard DD, Cain BS, McIntyre RC Jr. Cardiotrophin-1 attenuates endotoxin-induced acute lung injury. J Surg Res. 1999; 84:240-6. Go to original source... Go to PubMed...
  25. Talwar S, Downie PF, Squire IB, Barnett DB, Davies JD, Ng LL. An immunoluminometric assay for cardiotrophin-1: a newly identifi ed cytokine is present in normal human plasma and is increased in heart failure. Biochem Biophys Res Commun. 1999; 261:567- 71. Go to original source... Go to PubMed...
  26. Ishikawa M, Saito Y, Miyamoto Y, Harada M, Kuwahara K, Ogawa E, Nakagawa O, Hamanaka I, Kajiyama N, Takahashi N, Masuda I, Hashimoto T, Sakai O, Hosoya T, Nakao K. A heart-specifi c increase in cardiotrophin-1 gene expression precedes the establishment of ventricular hypertrophy in genetically hypertensive rats. J Hypertens. 1999; 17:807-16. Go to original source... Go to PubMed...
  27. Kuwahara K, Saito Y, Harada M, Ishikawa M, Ogawa E, Miyamoto Y, Hamanaka I, Kamitani S, Kajiyama N, Takahashi N, Nakagawa O, Masuda I, Nakao K. Involvement of cardiotrophin-1 in cardiac myocyte-nonmyocyte interactions during hypertrophy of rat cardiac myocytes in vitro. Circulation. 1999; 100:1116-24. Go to original source... Go to PubMed...
  28. Bordet T, Schmalbruch H, Pettmann B, Hagege A, Castelnau- Ptakhine L, Kahn A, Haase G. Adenoviral cardiotrophin-1 gene transfer protects pmn mice from progressive motor neuronopathy. J Clin Invest. 1999; 104:1077-85. Go to original source... Go to PubMed...
  29. Hishinuma S, Funamoto M, Fujio Y, Kunisada K, Yamauchi- Takihara K. Hypoxic stress induces cardiotrophin-1 expression in cardiac myocytes. Biochem Biophys Res Commun. 1999; 264:436- 40. Go to original source... Go to PubMed...
  30. Latchman DS. Cardiotrophin-1 (CT-1): a novel hypertrophic and cardioprotective agent. Int J Exp Pathol. 1999; 80:189-96. Go to original source... Go to PubMed...
  31. Signal transducer and activator of transcription 3 in the heart transduces not only a hypertrophic signal but a protective signal against doxorubicin-induced cardiomyopathy.. Proc Natl Acad Sci U S A. 2000; 97:315-9. Go to PubMed...
  32. Jougasaki M, Tachibana I, Luchner A, Leskinen H, Redfi eld MM, Burnett JC Jr. Augmented cardiac cardiotrophin-1 in experimental congestive heart failure. Circulation. 2000; 101:14-7. Go to original source... Go to PubMed...
  33. Richards CD, Langdon C, Deschamps P, Pennica D, Shaughnessy SG. Stimulation of osteoclast diff erentiation in vitro by mouse oncostatin M, leukaemia inhibitory factor, cardiotrophin-1 and interleukin 6: synergy with dexamethasone. Cytokine. 2000; 12:613- 21. Go to original source... Go to PubMed...
  34. Sano M, Fukuda K, Kodama H, Pan J, Saito M, Matsuzaki J, Takahashi T, Makino S, Kato T, Ogawa S. Interleukin-6 family of cytokines mediate angiotensin II-induced cardiac hypertrophy in rodent cardiomyocytes. J Biol Chem. 2000; 275:29717-23. Go to original source... Go to PubMed...
  35. Fukuzawa J, Booz GW, Hunt RA, Shimizu N, Karoor V, Baker KM, Dostal DE. Cardiotrophin-1 increases angiotensinogen mRNA in rat cardiac myocytes through STAT3 : an autocrine loop for hypertrophy. Hypertension. 2000; 35:1191-6. Go to original source... Go to PubMed...
  36. Funamoto M, Hishinuma S, Fujio Y, Matsuda Y, Kunisada K, Oh H, Negoro S, Tone E, Kishimoto T, Yamauchi-Takihara K. Isolation and characterization of the murine cardiotrophin-1 gene: expression and norepinephrine-induced transcriptional activation. J Mol Cell Cardiol. 2000; 32:1275-84. Go to original source... Go to PubMed...
  37. Talwar S, Squire IB, Downie PF, O'Brien RJ, Davies JE, Ng LL. Elevated circulating cardiotrophin-1 in heart failure: relationship with parameters of left ventricular systolic dysfunction. Clin Sci (Lond). 2000; 99:83-8. Go to original source... Go to PubMed...
  38. Hamanaka I, Saito Y, Nishikimi T, Magaribuchi T, Kamitani S, Kuwahara K, Ishikawa M, Miyamoto Y, Harada M, Ogawa E, Kajiyama N, Takahashi N, Izumi T, Shirakami G, Mori K, Inobe Y, Kishimoto I, Masuda I, Fukuda K, Nakao K. Eff ects of cardiotrophin- 1 on hemodynamics and endocrine function of the heart. Am J Physiol Heart Circ Physiol. 2000; 279:H388-96. Go to original source... Go to PubMed...
  39. Kuwahara K, Saito Y, Kishimoto I, Miyamoto Y, Harada M, Ogawa E, Hamanaka I, Kajiyama N, Takahashi N, Izumi T, Kawakami R, Nakao K. Cardiotrophin-1 phosphorylates akt and BAD, and prolongs cell survival via a PI3K-dependent pathway in cardiac myocytes. J Mol Cell Cardiol. 2000; 32:1385-94. Go to original source... Go to PubMed...
  40. Talwar S, Squire IB, Downie PF, Davies JE, Ng LL. Plasma N terminal pro-brain natriuretic peptide and cardiotrophin 1 are raised in unstable angina. Heart. 2000; 84:421-4. Go to original source... Go to PubMed...
  41. Aoyama T, Takimoto Y, Pennica D, Inoue R, Shinoda E, Hattori R, Yui Y, Sasayama S. Augmented expression of cardiotrophin-1 and its receptor component, gp130, in both left and right ventricles after myocardial infarction in the rat. J Mol Cell Cardiol. 2000; 32:1821-30. Go to original source... Go to PubMed...
  42. Railson J, Lawrence K, Stephanou A, Brar B, Pennica D, Latchman D. Cardiotrophin-1 reduces stress-induced heat shock protein production in cardiac myocytes. Cytokine 2000; 12:1741-4. Go to original source... Go to PubMed...
  43. Ghosh S, Ng LL, Talwar S, Squire IB, Galiñanes M. Cardiotrophin-1 protects the human myocardium from ischemic injury. Comparison with the fi rst and second window of protection by ischemic preconditioning. Cardiovasc Res. 2000; 48:440-7. Go to original source... Go to PubMed...
  44. Talwar S, Squire IB, Davies JE, Ng LL. The eff ect of valvular regurgitation on plasma Cardiotrophin-1 in patients with normal left ventricular systolic function. Eur J Heart Fail. 2000; 2:387-91 Go to original source... Go to PubMed...
  45. Asai S, Saito Y, Kuwahara K, Mizuno Y, Yoshimura M, Higashikubo C, Tsuji T, Kishimoto I, Harada M, Hamanaka I, Takahashi N, Yasue H, Nakao K. The heart is a source of circulating cardiotrophin-1 in humans. Biochem Biophys Res Commun. 2000; 279:320-3. Go to original source... Go to PubMed...
  46. Oppenheim RW, Wiese S, Prevette D, Armanini M, Wang S, Houenou LJ, Holtmann B, Gotz R, Pennica D, Sendtner M. Cardiotrophin-1, a muscle-derived cytokine, is required for the survival of subpopulations of developing motoneurons. J Neurosci. 2001; 21:1283-91. Go to original source... Go to PubMed...
  47. Talwar S, Downie PF, Squire IB, Davies JE, Barnett DB, Ng LL. Plasma N-terminal pro BNP and cardiotrophin-1 are elevated in aortic stenosis. Eur J Heart Fail. 2001; 3:15-9. Go to original source... Go to PubMed...
  48. Downie PF, Talwar S, Squire IB, Davies JE, Ng LL. Prolonged stability of endogenous cardiotrophin-1 in whole blood. Metabolism. 2001; 50:237-40. Go to original source... Go to PubMed...
  49. Hamanaka I, Saito Y, Yasukawa H, Kishimoto I, Kuwahara K, Miyamoto Y, Harada M, Ogawa E, Kajiyama N, Takahashi N, Izumi T, Kawakami R, Masuda I, Yoshimura A, Nakao K. Induction of JAB/SOCS-1/SSI-1 and CIS3/SOCS-3/SSI-3 is involved in gp130 resistance in cardiovascular system in rat treated with cardiotrophin- 1 in vivo. Circ Res. 2001; 88:727-32. Go to original source... Go to PubMed...
  50. Bordet T, Castelnau-Ptakhine L, Fauchereau F, Friocourt G, Kahn A, Haase G. Neuronal targeting of cardiotrophin-1 by coupling with tetanus toxin C fragment. Mol Cell Neurosci. 2001; 17:842-54. Go to original source... Go to PubMed...
  51. Mitsumoto H, Klinkosz B, Pioro EP, Tsuzaka K, Ishiyama T, O'Leary RM, Pennica D. Eff ects of cardiotrophin-1 (CT-1) in a mouse motor neuron disease. Muscle Nerve. 2001; 24:769-77. Go to original source... Go to PubMed...
  52. Ochiai W, Yanagisawa M, Takizawa T, Nakashima K, Taga T. Astrocyte diff erentiation of fetal neuroepithelial cells involving cardiotrophin-1-induced activation of STAT3. Cytokine. 2001; 14:264-71. Go to original source... Go to PubMed...
  53. Railson JE, Lawrence K, Buddle JC, Pennica D, Latchman DS. Heat shock protein-56 is induced by cardiotrophin-1 and mediates its hypertrophic eff ect. J Mol Cell Cardiol. 2001; 33:1209-21. Go to original source... Go to PubMed...
  54. Craig R, Wagner M, McCardle T, Craig AG, Glembotski CC. The cytoprotective eff ects of the glycoprotein 130 receptor-coupled cytokine, cardiotrophin-1, require activation of NF-kappa B. J Biol Chem. 2001; 276:37621-9. Go to original source... Go to PubMed...
  55. Brar BK, Stephanou A, Liao Z, O'Leary RM, Pennica D, Yellon DM, Latchman DS. Cardiotrophin-1 can protect cardiac myocytes from injury when added both prior to simulated ischaemia and at reoxygenation. Cardiovasc Res. 2001; 51:265-74. Go to original source... Go to PubMed...
  56. Bordet T, Lesbordes JC, Rouhani S, Castelnau-Ptakhine L, Schmalbruch H, Haase G, Kahn A. Protective eff ects of cardiotrophin- 1 adenoviral gene transfer on neuromuscular degeneration in transgenic ALS mice. Hum Mol Genet. 2001; 10:1925-33. Go to original source... Go to PubMed...
  57. Tsutamoto T, Wada A, Maeda K, Mabuchi N, Hayashi M, Tsutsui T, Ohnishi M, Fujii M, Matsumoto T, Yamamoto T, Wang X, Asai S, Tsuji T, Tanaka H, Saito Y, Kuwahara K, Nakao K, Kinoshita M. Relationship between plasma level of cardiotrophin-1 and left ventricular mass index in patients with dilated cardiomyopathy. J Am Coll Cardiol. 2001; 38:1485-90. Go to original source... Go to PubMed...
  58. Brar BK, Stephanou A, Pennica D, Latchman DS. CT-1 mediated cardioprotection against ischaemic re-oxygenation injury is mediated by PI3 kinase, Akt and MEK1/2 pathways. Cytokine. 2001; 16:93-6. Go to original source... Go to PubMed...
  59. Dolcet X, Soler RM, Gould TW, Egea J, Oppenheim RW, Comella JX. Cytokines promote motoneuron survival through the Janus kinase-dependent activation of the phosphatidylinositol 3-kinase pathway. Mol Cell Neurosci. 2001; 18:619-31. Go to original source... Go to PubMed...
  60. Talwar S, Squire IB, O'brien RJ, Downie PF, Davies JE, Ng LL. Plasma cardiotrophin-1 following acute myocardial infarction: relationship with left ventricular systolic dysfunction. Clin Sci (Lond). 2002; 102:9-14. Go to original source... Go to PubMed...
  61. Yao L, Kohno M, Noma T, Murakami K, Tsuji T, Yu Y, Ohmori K, Mizushige K, Fujita N, Hibi N. Acute eff ect of human cardiotrophin- 1 on hemodynamic parameters in spontaneously hypertensive rats and Wistar Kyoto rats. Hypertens Res. 2001; 24:717-21. Go to original source... Go to PubMed...
  62. Takimoto Y, Aoyama T, Iwanaga Y, Izumi T, Kihara Y, Pennica D, Sasayama S. Increased expression of cardiotrophin-1 during ventricular remodeling in hypertensive rats. Am J Physiol Heart Circ Physiol. 2002; 282:H896-901. Go to original source... Go to PubMed...
  63. Tsuruda T, Jougasaki M, Boerrigter G, Huntley BK, Chen HH, D'Assoro AB, Lee SC, Larsen AM, Cataliotti A, Burnett JC Jr. Cardiotrophin-1 stimulation of cardiac fi broblast growth: roles for glycoprotein 130/leukemia inhibitory factor receptor and the endothelin type A receptor. Circ Res. 2002; 90:128-34. Go to original source... Go to PubMed...
  64. Ng LL, O'Brien RJ, Demme B, Jennings S. Non-competitive immunochemiluminometric assay for cardiotrophin-1 detects elevated plasma levels in human heart failure. Clin Sci (Lond). 2002; 102:411-6. Go to original source... Go to PubMed...
  65. Liao Z, Brar BK, Cai Q, Stephanou A, O'Leary RM, Pennica D, Yellon DM, Latchman DS. Cardiotrophin-1 (CT-1) can protect the adult heart from injury when added both prior to ischaemia and at reperfusion. Cardiovasc Res. 2002; 53:902-10. Go to original source... Go to PubMed...
  66. Lesbordes JC, Bordet T, Haase G, Castelnau-Ptakhine L, Rouhani S, Gilgenkrantz H, Kahn A. In vivo electrotransfer of the cardiotrophin- 1 gene into skeletal muscle slows down progression of motor neuron degeneration in pmn mice. Hum Mol Genet. 2002; 11:1615-25. Go to original source... Go to PubMed...
  67. Jougasaki M, Larsen AM, Cataliotti A, Christiansen DC, Burnett JC Jr. Cardiotrophin-1 stimulates endothelin-1 via gp130 in vascular endothelial cells. Peptides. 2002; 23:1441-7. Go to original source... Go to PubMed...
  68. Toth G, Yang H, Anguelov RA, Vettraino J, Wang Y, Acsadi G. Gene transfer of glial cell-derived neurotrophic factor and cardiotrophin- 1 protects PC12 cells from injury: involvement of the phosphatidylinositol 3-kinase and mitogen-activated protein kinase kinase pathways. J Neurosci Res. 2002; 69:622-32. Go to original source... Go to PubMed...
  69. Zolk O, Ng LL, O'Brien RJ, Weyand M, Eschenhagen T. Augmented expression of cardiotrophin-1 in failing human hearts is accompanied by diminished glycoprotein 130 receptor protein abundance. Circulation. 2002; 106:1442-6. Go to original source... Go to PubMed...
  70. Sakamoto T, Kawazoe Y, Shen JS, Takeda Y, Arakawa Y, Ogawa J, Oyanagi K, Ohashi T, Watanabe K, Inoue K, Eto Y, Watabe K. Adenoviral gene transfer of GDNF, BDNF and TGF beta 2, but not CNTF, cardiotrophin-1 or IGF1, protects injured adult motoneurons after facial nerve avulsion. J Neurosci Res. 2003; 72:54-64. Go to original source... Go to PubMed...
  71. Lesbordes JC, Cifuentes-Diaz C, Miroglio A, Joshi V, Bordet T, Kahn A, Melki J. Therapeutic benefi ts of cardiotrophin-1 gene transfer in a mouse model of spinal muscular atrophy. Hum Mol Genet. 2003; 12:1233-9. Go to original source... Go to PubMed...
  72. Nomura N, Asano M, Saito T, Sasaki S, Suzuki H, Manabe T, Mishima A. Cardiotrophin-1 is a prophylactic against the development of chronic hypoxic pulmonary hypertension in rats. Ann Thorac Surg. 2003; 76:237-43. Go to original source... Go to PubMed...
  73. Bustos M, Beraza N, Lasarte JJ, Baixeras E, Alzuguren P, Bordet T, Prieto J. Protection against liver damage by cardiotrophin-1: a hepatocyte survival factor up-regulated in the regenerating liver in rats. Gastroenterology. 2003; 125:192-201. Go to original source... Go to PubMed...
  74. Song Y, Zhao L, Tao W, Laties AM, Luo Z, Wen R. Photoreceptor protection by cardiotrophin-1 in transgenic rats with the rhodopsin mutation s334ter. Invest Ophthalmol Vis Sci. 2003; 44:4069-75. Go to original source... Go to PubMed...
  75. Jougasaki M, Leskinen H, Larsen AM, Luchner A, Cataliotti A, Tachibana I, Burnett JC Jr. Ventricular cardiotrophin-1 activation precedes BNP in experimental heart failure. Peptides. 2003; 24:889- 92. Go to original source... Go to PubMed...
  76. Janjua S, Lawrence KM, Ng LL, Latchman DS. The cardioprotective agent urocortin induces expression of CT-1. Cardiovasc Toxicol. 2003; 3:255-62. Go to original source... Go to PubMed...
  77. Zhou D, Zheng X, Wang L, Stelmack G, Halayko AJ, Dorscheid D, Bai TR. Expression and eff ects of cardiotrophin-1 (CT-1) in human airway smooth muscle cells. Br J Pharmacol. 2003; 140:1237-44. Go to original source... Go to PubMed...
  78. Freed DH, Borowiec AM, Angelovska T, Dixon IM. Induction of protein synthesis in cardiac fi broblasts by cardiotrophin-1: integration of multiple signaling pathways. Cardiovasc Res. 2003; 60:365- 75. Go to original source... Go to PubMed...
  79. Freed DH, Moon MC, Borowiec AM, Jones SC, Zahradka P, Dixon IM. Cardiotrophin-1: expression in experimental myocardial infarction and potential role in post-MI wound healing. Mol Cell Biochem. 2003; 254:247-56. Go to original source... Go to PubMed...
  80. Zhang ZF, Liao WH, Yang QF, Li HY, Wu YM, Zhou XF. Protective eff ects of adenoviral cardiotrophin-1 gene transfer on rubrospinal neurons after spinal cord injury in adult rats. Neurotox Res. 2003; 5:539-48. Go to original source... Go to PubMed...
  81. Ruixing Y, Dezhai Y, Jiaquan L. Eff ects of cardiotrophin-1 on hemodynamics and cardiomyocyte apoptosis in rats with acute myocardial infarction. J Med Invest. 2004; 51:29-37. Go to original source... Go to PubMed...
  82. Jamshidi Y, Zourlidou A, Carroll CJ, Sinclair J, Latchman DS. Signal-transduction pathways involved in the hypertrophic eff ect of hsp56 in neonatal cardiomyocytes. J Mol Cell Cardiol. 2004; 36:381-92. Go to original source... Go to PubMed...
  83. Sauer H, Neukirchen W, Rahimi G, Grünheck F, Hescheler J, Wartenberg M. Involvement of reactive oxygen species in cardiotrophin- 1-induced proliferation of cardiomyocytes diff erentiated from murine embryonic stem cells. Exp Cell Res. 2004; 294:313- 24. Go to original source... Go to PubMed...
  84. Toh R, Kawashima S, Kawai M, Sakoda T, Ueyama T, Satomi- Kobayashi S, Hirayama S, Yokoyama M. Transplantation of cardiotrophin- 1-expressing myoblasts to the left ventricular wall alleviates the transition from compensatory hypertrophy to congestive heart failure in Dahl salt-sensitive hypertensive rats. J Am Coll Cardiol. 2004; 43:2337-47. Go to original source... Go to PubMed...
  85. Gard AL, Gavin E, Solodushko V, Pennica D. Cardiotrophin-1 in choroid plexus and the cerebrospinal fl uid circulatory system. Neuroscience. 2004; 127:43-52. Go to original source... Go to PubMed...
  86. Zheng X, Zhou D, Seow CY, Bai TR. Cardiotrophin-1 alters airway smooth muscle structure and mechanical properties in airway explants. Am J Physiol Lung Cell Mol Physiol. 2004; 287:L1165-71. Go to original source... Go to PubMed...
  87. Tian ZJ, Cui W, Li YJ, Hao YM, Du J, Liu F, Zhang H, Zu XG, Liu SY, Chen L, An W. Diff erent contributions of STAT3, ERK1/2, and PI3-K signaling to cardiomyocyte hypertrophy by cardiotrophin-1. Acta Pharmacol Sin. 2004; 25:1157-64.
  88. Zvonic S, Hogan JC, Arbour-Reily P, Mynatt RL, Stephens JM. Effects of cardiotrophin on adipocytes. J Biol Chem. 2004; 279:47572-9. Go to original source... Go to PubMed...
  89. Li YJ, Cui W, Tian ZJ, Hao YM, Du J, Liu F, Zhang H, Zu XG, Liu SY, Xie RQ, Yang XH, Wu YZ, Chen L, An W. Crosstalk between ERK1/2 and STAT3 in the modulation of cardiomyocyte hypertrophy induced by cardiotrophin-1. Chin Med J (Engl). 2004; 117:1135-42. Go to PubMed...
  90. Takahashi N, Saito Y, Kuwahara K, Harada M, Tanimoto K, Nakagawa Y, Kawakami R, Nakanishi M, Yasuno S, Usami S, Yoshimura A, Nakao K. Hypertrophic responses to cardiotrophin- 1 are not mediated by STAT3, but via a MEK5-ERK5 pathway in cultured cardiomyocytes. J Mol Cell Cardiol. 2005; 38:185-92. Go to original source... Go to PubMed...
  91. Zolk O, Engmann S, Münzel F, Krajcik R. Chronic cardiotrophin- 1 stimulation impairs contractile function in reconstituted heart tissue. Am J Physiol Endocrinol Metab. 2005; 288:E1214-21. Go to original source... Go to PubMed...
  92. Beraza N, Marqués JM, Martínez-Ansó E, Iñiguez M, Prieto J, Bustos M. Interplay among cardiotrophin-1, prostaglandins, and vascular endothelial growth factor in rat liver regeneration. Hepatology. 2005; 41:460-9. Go to original source... Go to PubMed...
  93. Nishikawa J, Sakuma K, Sorimachi Y, Yoshimoto K, Yasuhara M. Increase of Cardiotrophin-1 immunoreactivity in regenerating and overloaded but not denervated muscles of rats. Neuropathology. 2005; 25:54-65. Go to original source... Go to PubMed...
  94. López N, Díez J, Fortuño MA. Characterization of the protective eff ects of cardiotrophin-1 against non-ischemic death stimuli in adult cardiomyocytes. Cytokine. 2005; 30:282-92. Go to original source... Go to PubMed...
  95. Pemberton CJ, Raudsepp SD, Yandle TG, Cameron VA, Richards AM. Plasma cardiotrophin-1 is elevated in human hypertension and stimulated by ventricular stretch. Cardiovasc Res. 2005; 68:109- 17. Go to original source... Go to PubMed...
  96. Zvonic S, Baugh JE Jr, Arbour-Reily P, Mynatt RL, Stephens JM. Cross-talk among gp130 cytokines in adipocytes. J Biol Chem. 2005; 280:33856-63. Go to original source... Go to PubMed...
  97. Barnabé-Heider F, Wasylnka JA, Fernandes KJ, Porsche C, Sendtner M, Kaplan DR, Miller FD. Evidence that embryonic neurons regulate the onset of cortical gliogenesis via cardiotrophin- 1. Neuron. 2005; 48:253-65. Go to original source... Go to PubMed...
  98. Tanimoto K, Saito Y, Hamanaka I, Kuwahara K, Harada M, Takahashi N, Kawakami R, Nakagawa Y, Nakanishi M, Adachi Y, Shirakami G, Fukuda K, Yoshimura A, Nakao K. SOCS1/JAB likely mediates the protective eff ect of cardiotrophin-1 against lipopolysaccharide- induced left ventricular dysfunction in vivo. Circ J. 2005; 69:1412-7. Go to original source... Go to PubMed...
  99. González A, López B, Martín-Raymondi D, Lozano E, Varo N, Barba J, Serrano M, Díez J. Usefulness of plasma cardiotrophin-1 in assessment of left ventricular hypertrophy regression in hypertensive patients. J Hypertens. 2005; 23:2297-304. Go to original source... Go to PubMed...
  100. Fritzenwanger M, Kuethe F, Haase D, Jandt E, Figulla HR. Cardiotrophin-1 induces monocyte chemoattractant protein-1 synthesis in human umbilical vein endothelial cells. Cytokine. 2006; 33:46-51. Go to original source... Go to PubMed...
  101. Ateghang B, Wartenberg M, Gassmann M, Sauer H. Regulation of cardiotrophin-1 expression in mouse embryonic stem cells by HIF-1alpha and intracellular reactive oxygen species. J Cell Sci. 2006; 119:1043-52. Go to original source... Go to PubMed...
  102. Wu L, Zhao L, Zheng Q, Shang F, Wang X, Wang L, Lang B. Simvastatin attenuates hypertrophic responses induced by cardiotrophin- 1 via JAK-STAT pathway in cultured cardiomyocytes. Mol Cell Biochem. 2006; 284:65-71. Go to original source... Go to PubMed...
  103. Khan SQ, Kelly D, Quinn P, Davies JE, Ng LL. Cardiotrophin-1 predicts death or heart failure following acute myocardial infarction. J Card Fail. 2006; 12:635-40. Go to original source... Go to PubMed...
  104. Jiang ZS, Jeyaraman M, Wen GB, Fandrich RR, Dixon IM, Cattini PA, Kardami E. High- but not low-molecular weight FGF-2 causes cardiac hypertrophy in vivo; possible involvement of cardiotrophin- 1. J Mol Cell Cardiol. 2007; 42:222-33. Go to original source... Go to PubMed...
  105. Ho DW, Yang ZF, Lau CK, Tam KH, To JY, Poon RT, Fan ST. Therapeutic potential of cardiotrophin 1 in fulminant hepatic failure: dual roles in antiapoptosis and cell repair. Arch Surg. 2006; 141:1077-84. Go to original source... Go to PubMed...
  106. Gritman K, Van Winkle DM, Lorentz CU, Pennica D, Habecker BA. The lack of cardiotrophin-1 alters expression of interleukin-6 and leukemia inhibitory factor mRNA but does not impair cardiac injury response. Cytokine. 2006; 36: 9-16. Go to original source... Go to PubMed...
  107. Iniguez M, Berasain C, Martinez-Anso E, Bustos M, Fortes P, Pennica D, Avila MA, Prieto J. Cardiotrophin-1 defends the liver against ischemia-reperfusion injury and mediates the protective effect of ischemic preconditioning. J Exp Med. 2006; 203:2809-15. Go to original source... Go to PubMed...
  108. Fritzenwanger M, Meusel K, Foerster M, Kuethe F, Krack A, Figulla HR. Cardiotrophin-1 induces interleukin-6 synthesis in human umbilical vein endothelial cells. Cytokine. 2006; 36:101-6. Go to original source... Go to PubMed...
  109. Marquès JM, Belza I, Holtmann B, Pennica D, Prieto J, Bustos M. Cardiotrophin-1 is an essential factor in the natural defense of the liver against apoptosis. Hepatology 2007; 45:639-48. Go to original source... Go to PubMed...
  110. Cottone S, Nardi E, Mulc G, Vadalr A, Lorito MC, Riccobene R, Palermo A, Arsena R, Guarneri M, Cerasola G. Association between biomarkers of infl ammation and left ventricular hypertrophy in moderate chronic kidney disease. Clin Nephrol. 2007; 67:209-16. Go to original source... Go to PubMed...
  111. Drobic V, Cunnington RH, Bedosky KM, Raizman JE, Elimban VV, Rattan SG, Dixon IM. Diff erential and combined eff ects of cardiotrophin-1 and TGF-beta1 on cardiac myofi broblast proliferation and contraction. Am J Physiol Heart Circ Physiol. 2007; 293: H1053-64. Go to original source... Go to PubMed...
  112. López N, Varo N, Díez J, Fortuño MA. Loss of myocardial LIF receptor in experimental heart failure reduces cardiotrophin-1 cytoprotection. A role for neurohumoral agonists? Cardiovasc Res. 2007; 75:536-45. Go to original source... Go to PubMed...
  113. Fritzenwanger M, Meusel K, Foerster M, Kuethe F, Krack A, Figulla HR. Cardiotrophin-1 induces interleukin-6 synthesis in human monocytes. Cytokine. 2007; :37-44. Go to original source... Go to PubMed...
  114. Tsutamoto T, Asai S, Tanaka T, Sakai H, Nishiyama K, Fujii M, Yamamoto T, Ohnishi M, Wada A, Saito Y, Horie M. Plasma level of cardiotrophin-1 as a prognostic predictor in patients with chronic heart failure. Eur J Heart Fail. 2007; 9:1032-7. Go to original source... Go to PubMed...
  115. López B, Castellano JM, González A, Barba J, Díez J. Association of increased plasma cardiotrophin-1 with inappropriate left ventricular mass in essential hypertension. Hypertension. 2007; 50:977-83. Go to original source... Go to PubMed...
  116. González A, Ravassa S, Loperena I, López B, Beaumont J, Querejeta R, Larman M, Díez J. Association of depressed cardiac gp130-mediated antiapoptotic pathways with stimulated cardiomyocyte apoptosis in hypertensive patients with heart failure. J Hypertens 2007; 25:2148-57. Go to original source... Go to PubMed...
  117. Natal C, Fortuño MA, Restituto P, Bazán A, Colina I, Díez J, Varo N. Cardiotrophin-1 is expressed in adipose tissue and upregulated in the metabolic syndrome. Am J Physiol Endocrinol Metab. 2008; 294:E52-60. Go to original source... Go to PubMed...
  118. Ichiki T, Jougasaki M, Setoguchi M, Imamura J, Nakashima H, Matsuoka T, Sonoda M, Nakamura K, Minagoe S, Tei C. Cardiotrophin-1 Stimulates Intercellular Adhesion Molecule- 1 and Monocyte Chemoattractant Protein-1 in Human Aortic Endothelial Cells. Am J Physiol Heart Circ Physiol. 2007; Epub ahead of print Go to original source... Go to PubMed...
  119. Ruixing Y, Jinzhen W, Dezhai Y, Jiaquan L. Cardioprotective role of cardiotrophin-1 gene transfer in a murine model of myocardial infarction. Growth Factors. 2007; 25:286-94. Go to original source... Go to PubMed...
  120. Song J, Zhang YW, Yao AH, Yu Y, Hua ZY, Pu LY, Li GQ, Li XC, Zhang F, Sheng GQ, Wang XH. Adenoviral cardiotrophin-1 transfer improves survival and early graft function after ischemia and reperfusion in rat small-for-size liver transplantation model. Transpl Int. 2007; 19 [Epub ahead of print]. Go to original source...
  121. Liu J, Liu Z, Huang F, Xing Z, Wang H, Li Z. Pioglitazone inhibits hypertrophy induced by high glucose and insulin in cultured neonatal rat cardiomyocytes. Pharmazie 2007; 62:925-9. Go to PubMed...